milnacipran has been researched along with Briquet Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aleksic, B; Arao, M; Iritani, S; Ishihara, R; Kimura, H; Kurita, K; Ozaki, N; Ukai, K; Yamauchi, A | 1 |
Ikawa, M; Yamada, K | 1 |
Kinoshita, O; Miura, Y; Otani, K; Suzuki, A | 1 |
3 other study(ies) available for milnacipran and Briquet Syndrome
Article | Year |
---|---|
Effectiveness of low-dose milnacipran for a patient suffering from pain disorder with delusional disorder (somatic type) in the orofacial region.
Topics: Burning Mouth Syndrome; Cyclopropanes; Dose-Response Relationship, Drug; Female; Glossalgia; Humans; Milnacipran; Schizophrenia, Paranoid; Somatoform Disorders; Treatment Outcome | 2013 |
Effectiveness of milnacipran for a patient with pain disorder and long QT syndrome.
Topics: Adult; Antidepressive Agents, Tricyclic; Contraindications; Cyclopropanes; Drugs, Investigational; Facial Pain; Female; Humans; Long QT Syndrome; Milnacipran; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Treatment Outcome | 2010 |
Effectiveness and safety of milnacipran treatment for a patient with delusional disorder, somatic type taking multiple medications for concomitant physical diseases.
Topics: Aged; Antidepressive Agents; Cyclopropanes; Drug Interactions; Humans; Male; Milnacipran; Polypharmacy; Recurrence; Schizophrenia, Paranoid; Somatoform Disorders | 2010 |